ApoE4 is known for increasing the risk for dementia. New analysis of UK data suggests that it may also increase the risk for more severe outcomes from COVID-19 – double that of those with the ApoE3 gene variants. This finding held true independently of pre-existing dementia, cardiovascular disease and type 2 diabetes.
More research is needed to confirm the association and to understand the biological mechanisms that may be at play.
https://www.theguardian.com/world/2020/may/26/research-reveals-gene-role-in-both-dementia-and-severe-covid-19?CMP=Share_iOSApp_Other
Author: Kara Fitzgerald, ND
https://www.drkarafitzgerald.com/ KARA FITZGERALD, ND completed a post-doctorate in nutritional biochemistry/laboratory science with Richard Lord, Ph.D. Author: Case Studies in Integrative and Functional Medicine, contributing author: Laboratory Evaluations for Integrative and Functional Medicine; IFM’s Textbook for Functional Medicine. She lectures globally on functional medicine; is on faculty at IFM and practices in Connecticut.
